尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Ozden Rabia Gurses. Director active across 2 companies, notably Ocular Therapeutix, INC. In total, 8 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €64k. Activity tracked since 1 July 2022. The latest transaction was disclosed on 25 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Ozden Rabia Gurses is a declarant linked to Ocular Therapeutix, INC and Adverum Biotechnologies, Inc., where the listed role is Chief Medical Officer. She has 8 filings in total, and across the 8 recent filings available, reported sell transactions total 64419 EUR, with a date range from 2022-07-15 to 2025-12-10; the stated transaction nature is Attribution.